<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>22(1)</volume><submitter>Zhang Y</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>AarF domain-containing kinase 4 (ADCK4)-associated glomerulopathy is a mitochondrial nephropathy caused by mutations in the ADCK4 gene, which disrupt coenzyme Q10 biosynthesis.&lt;h4>Case presentation&lt;/h4>We report the case of a 25-year-old female patient with ADCK4-associated glomerulopathy presenting with proteinuria (and with no additional systemic symptoms). A known missense substitution c.737G > A (p.S246N) and a novel frameshift c.577-600del (p.193-200del) mutation were found. We followed the patient for 24 months during supplementation with coenzyme Q10 (20 mg/kg/d - 30 mg/kg/d) and describe the clinical course. In addition, we measured serum and urine coenzyme Q10 levels before and after coenzyme Q10 supplementation and compared them with those of healthy control su</pubmed_abstract><journal>BMC nephrology</journal><pagination>11</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7791994</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Urinary coenzyme Q10 as a diagnostic biomarker and predictor of remission in a patient with ADCK4-associated Glomerulopathy: a case report.</pubmed_title><pmcid>PMC7791994</pmcid><pubmed_authors>Jiang Y</pubmed_authors><pubmed_authors>Tao L</pubmed_authors><pubmed_authors>Ao L</pubmed_authors><pubmed_authors>Zhang Y</pubmed_authors><pubmed_authors>Liao X</pubmed_authors><pubmed_authors>Lv X</pubmed_authors><pubmed_authors>Dai Q</pubmed_authors><pubmed_authors>Peng Z</pubmed_authors><pubmed_authors>Yu Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Urinary coenzyme Q10 as a diagnostic biomarker and predictor of remission in a patient with ADCK4-associated Glomerulopathy: a case report.</name><description>&lt;h4>Background&lt;/h4>AarF domain-containing kinase 4 (ADCK4)-associated glomerulopathy is a mitochondrial nephropathy caused by mutations in the ADCK4 gene, which disrupt coenzyme Q10 biosynthesis.&lt;h4>Case presentation&lt;/h4>We report the case of a 25-year-old female patient with ADCK4-associated glomerulopathy presenting with proteinuria (and with no additional systemic symptoms). A known missense substitution c.737G > A (p.S246N) and a novel frameshift c.577-600del (p.193-200del) mutation were found. We followed the patient for 24 months during supplementation with coenzyme Q10 (20 mg/kg/d - 30 mg/kg/d) and describe the clinical course. In addition, we measured serum and urine coenzyme Q10 levels before and after coenzyme Q10 supplementation and compared them with those of healthy control su</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Jan</publication><modification>2025-04-26T16:49:37.035Z</modification><creation>2021-02-20T20:46:10Z</creation></dates><accession>S-EPMC7791994</accession><cross_references><pubmed>33413146</pubmed><doi>10.1186/s12882-020-02208-7</doi></cross_references></HashMap>